All stock lists
NatWest Group plc (New York Stock Exchange:NWG)
GB · Delayed Price · Currency is USD
Financial Services · Banks - Regional
17.00-0.23 (-1.33%)
Market cap
$34.1B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 18, 2007
Website
Insider Score
––Not scored
NWG Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From NWG’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $30.19B
- Net income
- $6.35B
- Net margin
- 21.0%
Leverage20 / 20
Little or no net debt.
- Total debt
- $76.19B
- Cash
- $77.11B
- Net debt / EBITDA
- -0.10x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $95.19B
- Current liabilities
- $488.89B
- Current ratio
- 0.19
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $0
- Free cash flow
- $0
- FCF margin
- 0.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 1993.8M
- Share growth (1y)
- -1.3%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
NWG Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 7.86 B | 7.38 B | 7.39 B | 7.55 B | 7.25 B | 7.27 B |
| Revenue Growth (YoY) | 8.39 % | 1.60 % | 1.85 % | 3.53 % | 1.78 % | 5.67 % |
| Cost of Revenue | 3.28 B | 3.03 B | 3.10 B | 3.21 B | 3.26 B | 3.29 B |
| Gross Profit | 4.58 B | 4.36 B | 4.29 B | 4.33 B | 3.99 B | 3.98 B |
| SG&A Expense | 1.37 B | 368.00 M | 440.00 M | 323.00 M | 337.00 M | 320.00 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.28 B | 2.33 B | 2.35 B | 2.15 B | 2.22 B | 2.17 B |
| Operating Income | 2.30 B | 2.03 B | 1.94 B | 2.18 B | 1.77 B | 1.81 B |
| Pretax Income | 2.30 B | 2.03 B | 1.94 B | 2.18 B | 1.77 B | 1.81 B |
| Tax Provision | 615.18 M | 526.00 M | 462.00 M | 502.00 M | 439.00 M | 471.00 M |
| Net Income | 1.69 B | 1.50 B | 1.48 B | 1.68 B | 1.33 B | 1.34 B |
| EPS (Basic) | 0.80 | 0.72 | 0.68 | 0.80 | 0.62 | 0.62 |
| EPS (Diluted) | 0.80 | 0.72 | 0.68 | 0.40 | 0.60 | 0.62 |
| Shares Outstanding | 1.99 B | 2.00 B | 2.00 B | 2.02 B | 2.02 B | 2.02 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.